Lincoln Pharmaceuticals Limited (NSE:LINCOLN)
India · Delayed Price · Currency is INR 594.40
-9.15 (-1.52%)
Sep 24, 2026, 2:44 PM IST
Lincoln Pharmaceuticals Market Cap
Lincoln Pharmaceuticals has a market cap or net worth of 12.08 billion as of September 23, 2026. Its market cap has increased by 8.89% in one year.
Market Cap
12.08B
Enterprise Value
9.71B
Revenue
6.94B
Ranking
n/a
PE Ratio
12.52
Stock Price
594.40
ChartMarket Cap Chart
Since October 21, 2004, Lincoln Pharmaceuticals's market cap has increased from 138.90M to 12.08B, an increase of 8,595.11%. That is a compound annual growth rate of 22.58%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 22, 2026 | 11.89B | 22.88% |
| Dec 31, 2025 | 9.68B | -38.62% |
| Dec 31, 2024 | 15.77B | 29.24% |
| Dec 29, 2023 | 12.20B | 71.47% |
| Dec 30, 2022 | 7.12B | -0.74% |
| Dec 31, 2021 | 7.17B | 47.47% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ind-Swift Laboratories | 35.27B |
| Sakar Healthcare | 26.44B |
| Indoco Remedies | 23.49B |
| Windlas Biotech | 22.75B |
| Beta Drugs | 21.34B |
| Anlon Healthcare | 15.34B |
| Jagsonpal Pharmaceuticals | 14.88B |
| Sigachi Industries | 11.70B |